CODX Gunggung Aset Perusahaan Co-Diagnostics Inc

The market trend for Co-Diagnostics, Inc. (CODX) analyzed on the GURU.Markets price chart demonstrates total assets at 31.53, while the company specializes in laboratory diagnostics. The business remains resilient to economic fluctuations, leveraging demand for medtech and clinical trial results. Management is effectively implementing molecular tests with a focus on global scaling, while growth is driven by cartridge sales and the launch of portable PCR systems.

Fundamental stock selection requires an analysis of a business's material base to filter out market noise and assess the enterprise's real value. This indicator, calculated inversely via ROA, measures the aggregate of all company resources, which in the case of Co-Diagnostics, Inc. (CODX) reflects the value of modernized lyophilization lines and laboratories, allowing for an assessment of production capacity scale through the structure of total balance sheet assets.